Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1835-1840

  Burton, Euan ^a   Gawande, Purushottam V ^a   Yakandawala, Nandadeva ^a   LoVetri, Karen ^a   Zhanel, George G ^b   Romeo, Tony ^c   Friesen, Albert D ^d   Madhyastha, Srinivasa ^a  

^a Kane Biotech Inc   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Medicure International Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; IODOACETAMIDE; N (1 PYRENYL)MALEIMIDE; N ACETYL DEXTRO GLUCOSAMINE 1 PHOSPHATE ACETYLTRANSFERASE; N ACETYLGLUCOSAMINE; N ETHYLMALEIMIDE; N PHENYLMALEIMIDE; N,N' (1,2 PHENYLENE)DIMALEIMIDE; PROTAMINE SULFATE; SILICONE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIOPLANKTON; BACTERIUM ISOLATE; BIOFILM; CATHETER INFECTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; URINE CATHETER;

EID: 33646462282     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1835-1840.2006     Document Type: Article

References (31)

1. Ahearn, D. G., D. T. Grace, M. J. Jennings, R. N. Borazjani, K. J. Boles, L. J. Rose, R. B. Simmons, and E. N. Ahanotu. 2000. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infection. Curr. Microbiol. 41:120-125.
2. Anderl, J. N., M. J. Franklin, and P. S. Stewart. 2000. Role of antibiotic penetration limitation of Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44:1818-1824.
3. Antohi, S., and A. Popescu. 1979. Lethal effect of protamine and histone on competent Bacillus subtilis cells. Mol. Gen. Genet. 170:345-349.
4. Brooks, T., and C. W. Keevil. 1997. A simple artificial urine for the growth of urinary pathogens. Lett. Appl. Microbiol. 24:203-206.
5. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
6. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
7. Darouiche, R. O., I. I. Raad, S. O. Heard, J. I. Thornby, O. C. Wenker, A. Gabrielli, J. Berg, N. Khardori, H. Hanna, R. Hachem, R. L. Harris, and G. Mayhall. 1999. A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 340:1-8.
8. Davies, D. 2003. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2:114-122.
9. Domenico, P., L. Baldassarri, P. E. Schoch, K. Kaehler, M. Sasatsu, and B. A. Cunha. 2001. Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob. Agents Chemother. 45:1417-1421.
10. Donlan, R. M. 2001. Biofilms and device-associated infections. Emerg. Infect. Dis. 7:277-281.
11. Filho, V. C., T. Pinhbiro, R. J. Nunes, and R. A. Yunes. 1994. Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships. Farmaco 49:675-677.
12. Flowers, R. H., K. J. Schwenzer, R. F. Kopel, M. J. Fish, S. I. Tucker, and B. M. Farr. 1989. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized controlled trial. JAMA 261:878-883.
13. Furusawa, T., T. Uete, T. Kawada, and A. Okuma. 1986. Resistance to cefsulodin and gentamicin in five areas of Japan between 1980 and 1983. J. Antimicrob. Chemother. 17:755-762.
14. Fux, C. A., J. W. Costerton, P. S. Stewart, and P. Stoodley. 2005. Survival strategies of infectious biofilms. Trends Microbiol. 13:34-40.
15. Givens, C. D., and R. P. Wenzel. 1980. Catheter-associated urinary tract infections in surgical patients: a controlled study of the excess morbidity and costs. J. Urol. 124:646-648.
16. Green, M. S., E. Rubinstein, and P. Amit. 1982. Estimating the effects of nosocomial infections on the length of hospitalization. J. Infect. Dis. 145:667-672.
17. Itoh, Y., X. Wang, B. J. Hinnebusch, J. F. Preston III, and T. Romeo. 2005. Depolymerization of β-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J. Bacteriol. 187:382-387.
18. Jackson, D. W., K. Suzuki, L. Oakford, J. W. Simecka, M. E. Hart, and T. Romeo. 2002. Bioiflm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J. Bacteriol. 184:290-301.
19. Johnson, J. R., P. Delavari, and M. Azar. 1999. Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob. Agents Chemother. 43:2990-2995.
20. Johnson, J. R., T. Berggren, and A. J. Conway. 1993. Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens. Antimicrob. Agents Chemother. 37:2033-2036.
21. Mengin-Lecreulx, D., and J. van Heijenoort. 1994. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis. J. Bacteriol. 176:5788-5795.
22. Murphy, E. F., J. R. Lu, J. Brewer, J. Russell, and J. Penfold. 1999. The reduced adsorption of proteins at the phosphoryl choline incorporated polymer-water interface. Langmuir 15:1313-1322.
23. Pompeo, F., J. van Heijenoort, and D. Mengin-Lecreulx. 1998. Probing the role of cysteine residues in glucosamine-1-phosphate acetyltranferase activity of the bifunctional GlmU protein from Escherichia coli: site-directed mutagenesis and characterization of the mutant enzymes. J. Bacteriol. 180:4799-4803.
24. Presterl, E., A. J. Grisold, S. Reichmann, A. M. Hirschl, A. Georgopoulos, and W. Graninger. 2005. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J. Antimicrob. Chemother. 55:45-50.
25. Raetz, C. R. H. 1996. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, p. 1035-1063. In F. C. Neidhardt, R. Curtiss III. J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanki, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C.
26. Sobho, F., A. E. Khoury, A. C. Zamboni, D. Davidson, and M. W. Mittelman. 1995. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 39:1281-1286.
27. Stickler, D. J. 1996. Bacterial biofilms and the encrustation of urethral catheters. Biofouling 94:293-305.
28. Stoodley, P., K. Sauer, D. G. Davies, and J. W. Costerton. 2002. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56:187-209.
29. Teichman, J. M. H., V. E. Abraham, P. C. Stein, and C. L. Parsons. 1994. Protamine sulfate and vancomycin are synergistic against Staphylococcus epidermidis prosthesis infection in vivo. J. Urol. 152:213-216.
30. Warren, J. W. 1987. Catheter-associated urinary tract infections. Infect. Dis. Clin. N. Am. 1:823-854.
31. Zentz, F., A. Valla, R. L. Guillou, R. Labia, A. G. Mathot, and D. Sirot. 2002. Synthesis and antimicrobial activities of N-substituted imides. Farmaco 57:421-426.